Latest California Healthline Stories
The Pennsylvania-based health chain Geisinger plans to offer DNA sequencing as part of regular patient care.
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
More than a dozen centers nationwide now ask terminal patients to allow speedy study of the diseases that kill them.
The newer images are more expensive, but it’s not yet clear if they are more effective in catching cancers that will kill.
Moly-99, as it’s called, is created in just six government-owned nuclear research reactors — none in North America — raising concerns about the reliability of the supply.
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctor’s office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
California has listed the active ingredient in Monsanto’s Roundup as a cancer-causing agent and will require warning labels on it starting next year. The company says the listing is unjustified and science is on its side.
Advertising for hospitals, unlike pharmaceutical companies, doesn’t have to be backed up by data or facts. Cheerful messages of hope can feel like a slap in the face to a dying patient.
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.